CA Patent

CA3111875A1 — Process for the preparation of lenvatinib

Assigned to Indena SpA · Expires 2020-03-12 · 6y expired

What this patent protects

The present invention relates to a process for the preparation of Lenvatinib of formula (I) from 4-amino-3-chloro-phenol and 4-chloro-7-methoxyquinoline-6-carboxamide.

USPTO Abstract

The present invention relates to a process for the preparation of Lenvatinib of formula (I) from 4-amino-3-chloro-phenol and 4-chloro-7-methoxyquinoline-6-carboxamide.

Drugs covered by this patent

indigotindisulfonate-sodium (INDIGOTINDISULFONATE SODIUM)

Patent Metadata

Patent number: CA3111875A1
Jurisdiction: CA
Classification: —
Expires: 2020-03-12
Drug substance claim: No
Drug product claim: No
Assignee: Indena SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.